Gastropexy in the Repair of Patients With Paraesophageal Hernias (PEH3)

November 13, 2023 updated by: Marcus Reuterwall Hansson, Ersta Diakoni

Can Gastropexy Improve the Efficacy of the Crural Repair in Patients With Paraesophageal Hernias? A Double Blind, Randomized, Multicenter Clinical Trial

Patients scheduled for surgery for primary paraesophageal herniation are randomized to either conventional surgical hernia repair or with the addition of gastropexy.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Patient undergoing surgery for primary paraesophageal herniation, are randomized to either the control group or interventional group. The control group have a crural repair alone to which is added a short and floppy Nissen fundoplication. The interventional arm contains the addition of a gastropexy which incorporates fixation of the left part of the wrap to the diaphragm as well as the posterior part to the right crus. Finally the minor curvature of the stomach is sutured left to the midline of the abdominal wall.

The patients are examined by computed tomography before surgery and at 1 and 3 years after surgery.

SF-36 (global quality of Life instrument), GSRS (Gastrointestinal Symptoms Rating Scale), Reflux frequency issues and Watson's dysphagia score are completed before and at 3 and 6 month as well as 1 and 3 years after surgery.

Study Type

Interventional

Enrollment (Estimated)

124

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • all patients with primary hiatus hernia type II-IV who are deemed suitable for surgery

Exclusion Criteria:

  • American Society of Anesthesiologists physical status-system (ASA) >III
  • inability to understand the nature of the purpose of the study and/or to give informed consent.
  • Achalasia or another severe esophageal motor disorder
  • Previous major upper GI surgery(including previous hiatal hernia repair)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard paraesophageal hernia repair
Standard paraesophageal hernia repair(Crura suture with total (Nissen) fundoplication))
Active Comparator: Standard paraesophageal hernia repair +gastropexy
Standard paraesophageal hernia repair with the addition of gastropexy(anterior, posterior and left gastropexy)

In the intervention group, the following three additional attachment points between the stomach and surrounding anatomical structures will be completed with non-absorbable suture material:

  1. The left lateral part of the fundus flap is adapted to the diaphragm at its flat tendinous part of the diaphragm lateral to the hiatus, with a 2-3 cm long continuous non-absorbable suture ("left postero-lateral gastropexy").
  2. The anterior stomach wall is attached to the abdominal wall with a 2-3 cm long continuous non-absorbable suture ("anterior gastropexy").
  3. The posterior fundus is adapted to the right crus with a 2-3 cm long non-absorbable suture ("right-posterior gastropexy").

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recurrence of hernia at 1 year after surgery
Time Frame: 1 year
Computer tomography of abdomen and thorax
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recurrence of hernia at 3 years after surgery
Time Frame: 3 year
Computer tomography of abdomen and thorax
3 year
Complications after surgery
Time Frame: at approximately 10 weeks after surgery
Symptomatic recurrence
at approximately 10 weeks after surgery
Changes in the patients perception of gastrointestinal symptoms after surgery
Time Frame: 3 months, 12 months, 24 months and 36 months

GSRS = The Gastrointestinal Symptom Rating Scale. Scoring;The questionnaire, which contains 15 items, uses a seven-graded Likert scale, where 1 represents the most positive option and 7 the most negative one.

A mean value for the items in each dimension should be calculated:

Diarrhoea syndrome: 11. Increased passage of stools 12. Loose stools 14. Urgent need for defecation Indigestion syndrome: 6. Borborygmus 7. Abdominal distension 8. Eructation 9. Increased flatus Constipation syndrome: 10. Decreased passage of stools 13. Hard stools 15. Feeling of incomplete evacuation Abdominal pain syndrome: 1. Abdominal pain 4. Sucking sensations 5. Nausea and vomiting Reflux syndrome: 2. Heartburn 3. Acid regurgitation) Watson dysphagia score and clinical evaluation. The questionnaire, which contains 15 items, uses a seven-graded Likert scale, where 1 represents the most positive option and 7 the most negative one.

3 months, 12 months, 24 months and 36 months
Changes in the patients perception of dysphagia after surgery - Dakkak
Time Frame: 3 months, 12 months, 24 months and 36 months
The Dakkak dysphagia score is a questionnaire for assessing benign dysphagia, including nine questions regarding the frequency (always, sometimes, or never) of swallowing difficulties with different food consistencies (liquid, semisolid, and solid foods). The final score ranges from 0 to 45, where 45 represents the most severe dysphagia.
3 months, 12 months, 24 months and 36 months
Changes in the patients perception of dysphagia after surgery
Time Frame: 3 months, 12 months, 24 months and 36 months
Dysphagia for liquids and solids were recorded within a four-graded scale stating the frequency of dysphagia episodes with an arbitrary (empirical) cut off for clinical significance. The same dysphagia scoring was also used in a previous rct, from the same institution, comparing different types of antireflux procedures in open surgery.
3 months, 12 months, 24 months and 36 months
Length of stay at the hospital after surgery
Time Frame: at approximately 10 weeks after surgery
Information from patients journal
at approximately 10 weeks after surgery
Manometric characteristics of the oesophagus
Time Frame: 1 year

To assess oesophageal function at 1 yr postoperative High resolution manometry(HRM) will be performed.

Postoperative primary peristalsis will be classified according to the Chicago classification.

1 year
Esophageal distensibility characteristics of the oesophagus
Time Frame: 1 year

To assess oesophageal function at 1 yr postoperative functional lumen imaging probe (endoFLIP) will be performed.

Postoperative secondary peristalsis and distensibility in the distal oesophagus will be characterized with the endo-FLIP system. Measurement unit is mm2/mmHg.

1 year
Changes in the patients perception of quality of life after surgery
Time Frame: 3 months, 12 months, 24 months and 36 months
SF-36 (Quality of Life issues) The SF-36 is comprised of 36 items that assess eight health concepts: physical functioning, role limitations caused by physical health problems, role limitations caused by emotional problems, social functioning, emotional well-being, energy/fatigue, pain, and general health perceptions. Higher scores mean a better outcome. Scoring is from 0-100. A mean score of 50 has been articulated as normative value.
3 months, 12 months, 24 months and 36 months
Number of study participants administered post-operative analgetics in addition to standard baseline postoperative analgetic regime.
Time Frame: at approximately 10 weeks after surgery
Information from patients eletcronic drug journal
at approximately 10 weeks after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Anders Thorell, Professor, Ersta Diakoni

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2023

Primary Completion (Estimated)

August 2, 2027

Study Completion (Estimated)

August 2, 2030

Study Registration Dates

First Submitted

September 19, 2023

First Submitted That Met QC Criteria

October 24, 2023

First Posted (Actual)

October 30, 2023

Study Record Updates

Last Update Posted (Actual)

November 15, 2023

Last Update Submitted That Met QC Criteria

November 13, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Dnr 2023-01956-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Paraesophageal Hernia

Clinical Trials on Gastropexy

3
Subscribe